Use of sodium-glucose co-transporter 2 inhibitors and glucagon-like peptide-1 receptor agonists according to the 2019 ESC guidelines and the 2019 ADA/EASD consensus report in a national population of patients with type 2 diabetes
If you want to hide personal information on the label, use a permanent marker to cover it before disposal.
No, the results are not permanent and require periodic maintenance sessions along with strict, daily sun protection
However, in December 2023, the FDA seized thousands of units of Ozempic counterfeits
So the real choice is between two molecules
Unlike weight loss medications that work for a fixed period, tirzepatide is designed for chronic use, meaning the decision to discontinue depends on individual health milestones, metabolic response, and lifestyle factors rather than a preset timeline